Early optic neuropathy during pegylated alfa 2-B interferon and ribavirin HCV treatment. A case report

摘要

IntroductionHepatitis C viral infection (HCV) represents an important health problem worldwide. Natural evolution, with its complications, remains a high cause of mortality and morbidity. Interferon (IFN) treatment, along with ribavirin (RBV), was for several years the standard of care. However, many adverse effects have been described during this therapy. We report a very elusive case of optic neuropathy.